| Literature DB >> 21318024 |
Tejaswini P Reddy1, Maria Manczak, Marcus J Calkins, Peizhong Mao, Arubala P Reddy, Ulziibat Shirendeb, Byung Park, P Hemachandra Reddy.
Abstract
The purpose of this study was to determine the neurotoxicity of two commonly used herbicides: picloram and triclopyr and the neuroprotective effects of the mitochondria-targeted antioxidant, SS31. Using mouse neuroblastoma (N2a) cells and primary neurons from C57BL/6 mice, we investigated the toxicity of these herbicides, and protective effects of SS1 peptide against picloram and triclopyr toxicity. We measured total RNA content, cell viability and mRNA expression of peroxiredoxins, neuroprotective genes, mitochondrial-encoded electron transport chain (ETC) genes in N2a cells treated with herbicides and SS31. Using primary neurons from C57BL/6 mice, neuronal survival was studied in neurons treated with herbicides, in neurons pretreated with SS31 plus treated with herbicides, neurons treated with SS31 alone, and untreated neurons. Significantly decreased total RNA content, and cell viability in N2a cells treated with picloram and triclopyr were found compared to untreated N2a cells. Decreased mRNA expression of neuroprotective genes, and ETC genes in cells treated with herbicides was found compared to untreated cells. Decreased mRNA expression of peroxiredoxins 1-6 in N2a cells treated with picloram was found, suggesting that picloram affects the antioxidant enzymes in N2a cells. Immunofluorescence analysis of primary neurons revealed that decreased neuronal branching and degenerating neurons in neurons treated with picloram and triclopyr. However, neurons pretreated with SS31 prevented degenerative process caused by herbicides. Based on these results, we propose that herbicides--picloram and triclopyr appear to damage neurons, and the SS31 peptide appears to protect neurons from herbicide toxicity.Entities:
Keywords: Mitochondria-targeted antioxidant; Picloram; Szeto-Schiller peptide 31; Triclopyr; electron transport chain; herbicides; mouse neuroblastoma cells; mouse primary hippocampal neurons; oxidative stress
Mesh:
Substances:
Year: 2011 PMID: 21318024 PMCID: PMC3037070 DOI: 10.3390/ijerph8010203
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Experimental strategy of mouse neuroblastoma (N2a) cells pretreated with SS31 and then treated with the herbicides picloram and triclopyr.
Oligonucleotide primers used for real-time RT-PCR analysis.
| Gene | DNA Sequences (5′–3′) | PCR Product Size |
|---|---|---|
| Antioxidant Enzyme Proteins (Peroxiredoxins) | ||
| Prx1 | Forward Primer TGGCTCGACCCTGCTGATAG | 61 |
| Reverse Primer GGAGCAGGATACCCAATTTTTG | ||
| Prx2 | Forward Primer CCCCTGAATATCCCTCTGCTT | 57 |
| Reverse Primer CGCCGTAATTCTGGGACAA | ||
| Prx3 | Forward Primer GGCCCCATTTCTTGGAT | 60 |
| Reverse Primer CAGGGCAGGCTAAGGGAAAG | ||
| Prx4 | Forward Primer CCTGTTGCGGACCGAATCT | 55 |
| Reverse Primer GGGTCCGGAACCGTTCAT | ||
| Prx5 | Forward Primer CCCGATCAAGGTGGGAGAT | 56 |
| Reverse Primer CCCGGTTCCCCTTCAAATA | ||
| Prx6 | Forward Primer TCTGGCAAAAAATACCTCCGTTA | 58 |
| Reverse Primer GCCCCAATTTCCGCAAAG | ||
| Neuroprotective Genes | ||
| FOXOs1 | Forward Primer CCCGTCCTAGGCACGAACT | 69 |
| Reverse Primer ACGCGCCCAGAACTTAACTTC | ||
| PGC1α | Forward Primer GGACAGTCTCCCCGTGGAT | 57 |
| Reverse Primer TCCATCTGTCAGTGCATCAAATG | ||
| NMDAR | Forward Primer GGTCAGTTCTGTCCTGCACATC | 65 |
| Reverse Primer TGACTCTCCCGCGGAAAC | ||
| Mitochondrial Electron Transport Chain Genes | ||
| Complex I-NADHsubunit1 | Forward Primer CGGGCCCCCTTCGAC | 72 |
| Reverse Primer GGCCGGCTGCGTATTCT | ||
| Complex II Cyt. B | Forward Primer TTATCGCGGCCCTAGCAA | 70 |
| Reverse Primer TAATCCTGTTGGGTTGTTTGATCC | ||
| Complex IV COX1 | Forward Primer GAAGAGACAGTGTTTCATGTGGTGT | 75 |
| Reverse Primer TCCTGGGCCTTTCAGGAATA | ||
| Complex V ATPase-6 | Forward Primer TGTGGAAGGAAGTGGGCAA | 73 |
| Reverse Primer CCACTATGAGCTGGAGCCGT | ||
| Housekeeping Genes | ||
| Beta Actin | Forward Primer ACGGCCAGGTCATCACTATTC | 65 |
| Reverse Primer AGGAAGGCTGGAAAAGAGCC | ||
| GAPDH | Forward Primer TTCCCGTTCAGCTCTGGG | 59 |
| Reverse Primer CCCTGCATCCACTGGTGC | ||
The total RNA content in mouse neuroblastoma (N2a) cells pretreated with SS31 and then treated with picloram and triclopyr.
| Mean Total RNA (in μg) | SE | Difference | Dunnett p-value | |
|---|---|---|---|---|
| Untreated N2a | 29.3 | 0.45 | ||
| Picloram | 12.7 | 0.45 | −16.60 | <0.0001 |
| SS31 + picloram | 23.6 | 0.45 | −5.67 | <0.0001 |
| Triclopyr | 9.2 | 0.45 | −20.09 | <0.0001 |
| SS31 + triclopyr | 20.0 | 0.45 | −9.3 | <0.0001 |
| SS31 | 32.0 | 0.45 | 2.65 | 0.0023 |
Note: One-way ANOVA was used to compare neurons treated with the herbicides and those that were not treated. Exact p-values are provided. These p-values were obtained using permutation tests. Dunnett’s multiple comparison procedures with the untreated group as a control was used to adjust an experiment-wise error rate. Since we designed the study to compare each herbicide-treated group to the untreated group, we used Dunnett’s multiple comparison adjustment to compare each treatment to the control.
Cell viability of mouse neuroblastoma cells pretreated with SS31 and then treated with picloram and triclopyr.
| Mean optical density of MTT assay solution | SE | Difference | Dunnett p-value | |
|---|---|---|---|---|
| Untreated N2a | 1.27 | 0.0266 | ||
| Picloram | 0.66 | 0.0266 | −0.61 | <0.0001 |
| SS31 + picloram | 0.72 | 0.0266 | −0.54 | <0.0001 |
| Triclopyr | 0.66 | 0.0266 | −0.60 | <0.0001 |
| SS31 + triclopyr | 0.72 | 0.0266 | −0.54 | <0.0001 |
| SS31 | 1.36 | 0.0266 | 0.09 | 0.1119 |
Note: Same note as in Table 2.
Differences in mRNA fold changes in N2a cells pretreated with SS31 and then treated with picloram and triclopyr (SYBR-Green chemistry based on quantitative real-time RT-PCR).
| Marker | N2a cells treated with picloram | N2a cells pretreated with SS31 and then treated with picloram | N2a cells treated with triclopyr | N2a cells pretreated with SS31 and then treated with triclopyr | N2a cells treated with SS31 |
|---|---|---|---|---|---|
| Prx1 | 0.48 (52% ⇓) | 0.79 (21% ⇓) | 1.12 (12% ⇑) | 1.37 (37% ⇑) | 1.20 (20% ⇑) |
| Prx2 | 0.23 (77% ⇓) | 1.16 (16% ⇑) | 1.7 (70% ⇑) | 2.03 (103% ⇑) | 1.10 (10% ⇑) |
| Prx3 | 0.35 (65% ⇓) | 0.69 (31% ⇓) | 1.3 (30% ⇑) | 1.71 (71% ⇑) | 1.00 |
| Prx4 | 0.52 (52% ⇓) | 0.90 | 0.99 | 2.01 (101% ⇑) | 1.25 (25% ⇑) |
| Prx5 | 0.11 (89% ⇓) | 0.37 (63% ⇓) | 1.41 (41% ⇑) | 1.48 (48% ⇑) | 1.40 (40% ⇑) |
| Prx6 | 0.93 | 1.12 (12% ⇑) | 1.02 | 0.93 | 1.30 (30%⇑) |
| PGC1α | 1.56 (56% ⇑) | 1.55 (55% ⇑) | 1.45 (45% ⇑) | 1.89 (89% ⇑) | 2.75 (175% ⇑) |
| FOXO1 | 0.32 (68% ⇓) | 0.52 (48% ⇓) | 0.28 (72% ⇓) | 0.93 (7% ⇓) | 0.45 (55% ⇓) |
| NMDAR | 0.50 (50% ⇓) | 0.65 (35% ⇓) | 0.21 (79% ⇓) | 0.93 | 0.89 (11% ⇓) |
| NADH sub1 | 0.13 (87% ⇓) | 0.22 (78% ⇓) | 0.20 (80% ⇓) | 0.36 (64% ⇓) | 0.93 |
| Cyt. B | 0.54 (46% ⇓) | 0.69 (31% ⇓) | 0.74 (26% ⇓) | 0.98 (2% ⇓) | 1.94 (94% ⇑) |
| COX1 | 0.40 (60% ⇓) | 0.75 (25% ⇓) | 0.72 (28% ⇓) | 1.14 (14% ⇑) | 0.93 |
| ATP-6 | 0.39 (61% ⇓) | 0.58 (42% ⇓) | 0.57 (43% ⇓) | 0.89 (11% ⇓) | 1.11 (11% ⇑) |
Note: 1 fold mRNA expression means no change between experimental samples (N2a cells treated with picloram and triclopyr, N2a cells pretreated with SS31 and then treated with picloram and triclopyr, and N2a cells pretreated with only SS31) versus untreated N2a cells.
>1 fold mRNA expression indicates increased mRNA in untreated N2a cells.
<1 fold mRNA expression indicates decreased mRNA in untreated N2a cells.
Figure 2Primary neurons from C57BL/6 mice treated with picloram (C), triclopyr (D) and SS31 (B). The neurons treated with picloram (C) and triclopyr (D) exhibited damaged morphology: a loss of projections and network, compared to the untreated neurons (A). The neurons that were treated with SS31 (B) showed increased neuronal branching and network. Image a shows cortical neurons and photographs taken using phase-contrast microscope at 20x the original magnification. Image b shows immunofluorescence analysis of beta III tubulin antibody in hippocampal neurons treated with 1 nM SS31 (B), 5 mM picloram (C), and 3 mM triclopyr (D). Photographs were taken using fluorescence microscope at 100x the original magnification. Green arrows indicate intact/healthy neurons, and white arrows, degenerative neurons.
Figure 3Primary neurons from mice pretreated with SS31 and then with picloram (B) and triclopyr (C). The neurons exhibited intact projections/network, similar to those in the untreated neurons (A). Image a shows primary cortical neurons and photographs taken with a phase-contrast microscope at 20x the original magnification. Image b shows immunofluorescence analysis of the beta III tubulin antibody in primary hippocampal neurons pretreated with 1 nM SS31 and then treated with 5 mM picloram (B) and 3 mM triclopyr (C). Pretreatment with SS31 prevented neuronal damage caused by picloram and triclopyr. Photographs were taken using a fluorescence microscope at 100x the original magnification. Green arrows indicate intact/healthy neurons, and white arrows, degenerative neurons.